Literature DB >> 9099981

p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis.

M Schmid1, K Janssen, B Dockhorn-Dworniczak, D Metze, B W Zelger, T A Luger, K W Schmid.   

Abstract

The aim of the present study was to assess a possible role of the tumour suppressor gene p53 in neuroendocrine (Merkel cell) carcinoma of the skin with regard to tumour development and tumour progression. p53 was investigated in a series of routinely processed Merkel cell carcinomas, with application of four different p53 antibodies (CM-1, PAb1801, DO7, and PAb240) to 25 carcinomas and screening for p53 mutations of exons 4-8 by single-strand conformation polymorphism (SSCP) analysis in 9 cases. All 25 tumours in the present series showed the characteristic microscopic and immunohistochemical features of Merkel cell carcinoma of the skin. In 5 of the 25 Merkel cell carcinomas investigated 5-10% of tumour cell nuclei showed a positive p53 reaction with at least one anti-p53 antibody. A few scattered p53 positive nuclei were found in an additional 9 cases. The remaining 11 cases completely lacked p53 immunostaining. SSCP analysis of exons 4-8 revealed no significant alterations in the mobility shift of the single strand DNAs in the five cases with 5-10% p53-immunoreactive tumour nuclei or in five cases lacking p53 accumulation significant. Our results suggest that alterations of the p53 gene play only a minor part in the development or progression of Merkel cell carcinoma of the skin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099981     DOI: 10.1007/bf01324807

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

1.  Possible Relation of p53 and mdm-2 Oncoprotein Expression in Thyroid Carcinoma: A Molecular-Pathological and Immunohistochemical Study on Paraffin-Embedded Tissue.

Authors:  Kurt W. Schmid; Agnes Bankfalvi; Swantja Mucke; Dietmar Ofner; Kristina Riehemann; Soren Schroder; Andrea Stucker; Martin Totsch; Barbara Dockhorn-Dworniczak
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

2.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

3.  Polymerase chain reaction amplification products separated on rehydratable polyacrylamide gels and stained with silver.

Authors:  R C Allen; G Graves; B Budowle
Journal:  Biotechniques       Date:  1989 Jul-Aug       Impact factor: 1.993

4.  Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation.

Authors:  C Campbell; A G Quinn; B Angus; P M Farr; J L Rees
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  Primary cutaneous neuroendocrine carcinoma (Merkel cell tumor). An adnexal epithelial neoplasm.

Authors:  P J Heenan; J M Cole; D V Spagnolo
Journal:  Am J Dermatopathol       Date:  1990-02       Impact factor: 1.533

7.  Abnormal expression of wild type p53 protein in normal cells of a cancer family patient.

Authors:  D M Barnes; A M Hanby; C E Gillett; S Mohammed; S Hodgson; L G Bobrow; I M Leigh; T Purkis; C MacGeoch; N K Spurr
Journal:  Lancet       Date:  1992-08-01       Impact factor: 79.321

8.  Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.

Authors:  J Bártek; J Bártková; J Lukás; Z Stasková; B Vojtĕsek; D P Lane
Journal:  J Pathol       Date:  1993-01       Impact factor: 7.996

9.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

10.  Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma.

Authors:  I Yana; T Nakamura; E Shin; K Karakawa; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1992-11
View more
  5 in total

Review 1.  Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.

Authors:  Shailender Bhatia; Olga Afanasiev; Paul Nghiem
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

2.  Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus.

Authors:  Scott J Rodig; Jingwei Cheng; Jacek Wardzala; Andrew DoRosario; Jessica J Scanlon; Alvaro C Laga; Alejandro Martinez-Fernandez; Justine A Barletta; Andrew M Bellizzi; Subhashini Sadasivam; Dustin T Holloway; Dylan J Cooper; Thomas S Kupper; Linda C Wang; James A DeCaprio
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

3.  Mutation analysis of P73 and TP53 in Merkel cell carcinoma.

Authors:  M Van Gele; M Kaghad; J H Leonard; N Van Roy; J M Naeyaert; M L Geerts; S Van Belle; V Cocquyt; J Bridge; R Sciot; C De Wolf-Peeters; A De Paepe; D Caput; F Speleman
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

4.  Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse Model.

Authors:  Masahiro Shuda; Anna Guastafierro; Xuehui Geng; Yoko Shuda; Stephen M Ostrowski; Stefan Lukianov; Frank J Jenkins; Kord Honda; Stephen M Maricich; Patrick S Moore; Yuan Chang
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

5.  Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases.

Authors:  Akinori Egashira; Masaru Morita; Reiko Kumagai; Ken-Ichi Taguchi; Masanobu Ueda; Shohei Yamaguchi; Manabu Yamamoto; Kazuhito Minami; Yasuharu Ikeda; Yasushi Toh
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.